Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)

Market Cap	80.05M
Revenue (ttm)	15.71M
Net Income (ttm)	-27.05M
Shares Out	1.23B
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,998,700
Average Volume	7,733,145
Open	0.0640
Previous Close	0.0650
Day's Range	0.0620 - 0.0670
52-Week Range	0.0260 - 0.0890
Beta	n/a
RSI	55.90
Earnings Date	Feb 12, 2026

About SGXC:9G2

Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theragnostic treatments, general diagnostics and health screening, and aesthetic services; and radiation therapy and medical oncology services comprise proton beam therapy, photon radiation therapy, and medical oncology services. It provides clinic and ima...

• Industry: Medical Laboratories
• Founded: 2011
• Country: Singapore
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 9G2

Financial Performance

In 2025, SGXC:9G2's revenue was 15.71 million, a decrease of -5.63% compared to the previous year's 16.65 million. Losses were -27.05 million, -27.75% less than in 2024.